Our results may be due to MASLD and atherosclerosis having common pathogenesis, including endothelial dysfunction, systemic inflammation, hepatic insulin resistance, increased oxidative stress, and changes in lipid metabolism [32–34]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.